ANDREA PARRISH: Open Payments
NPI 1952970964 · DYSART, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 44 payments from 14 companies in 2025. Trend: 2023 $77 · 2024 $459 · 2025 $1,063
Food & beverage: $863Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $209 |
| ABBVIE INC. | 7 | $127 |
| Novartis Pharmaceuticals Corporation | 4 | $121 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $88 |
| LEO Pharma Inc. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| Biofrontera Inc. | 3 | $57 |
| Amgen Inc. | 3 | $57 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, ADBRY, Sotyktu, ILUMYA, COSENTYX, OTEZLA.
Industry payments across PA — which companies pay providers there.
